| Bronchial asthma is a kind of chronic allergic inflammatory disease of airway, which consists of inflammatory cells (including the eosinophils, the mast cells and T Lymphocytes), constituent cells (Smooth Muscle cells, airway epithelial cells) and cellular components. According to local area investigation, the incidence of asthma of our country is about 0.5% to 1%, the specific area is up to 5.29%. The mortality rate of our country reaches is up to 0.367‰, resides the first place in the world. The disease may be assigned to "Asthma" in Traditional Chinese Medicine, The TCM has found that asthma remission phase includes "lung deficiency"," spleen deficiency"," kidney deficiency" in different degree. Traditional Chinese Medicine considers that the nature of the origin of the asthma is disturbance of myocardium metabolism which regards "lung deficiency"," spleen deficiency"," kidney deficiency" as the basic feature. It leads to decreased environmental adaptability of body, which mainly manifested as allergic airway inflammation caused by stagnation of phlegm-damp in the lung. As the most characteristic "Non-time therapy" in Traditional Chinese Medicine, treating winter disease in summer means that some diseases which usually happens or aggravates in the winter, like bronchial asthma, were relieved in summer. During this time, on the Basis of dialectical treatment, patients can be treated with oral traditional Chinese medicine or external traditional Chinese medicine, which prevents the recurrence or aggravation of asthma.As the preferred method of treating winter disease in summer, is based on some theories of the Canon of Internal Medicine. It holds that "man is an integral part of nature". "Twelve channels in our body play a role in communicating the organs with body surface". "The channels determine the life and death and cure the diseases by regulating excess and deficiency, which must be canalized". Under guidance of Chinese Medical Holistic, the treatment cures diseases by drug absorption’s direct effect in specific part and point stimulation’s indirect effect on channel-qi. The treatment is simple, accurate and sensitive, and has the advantage of introducing the drug to the affected area, with short therapeutic duration and little side effect.Research background and objective:The research team leaded by my tutor has used point-application, treating winter disease in summer to prevent the recurrence of bronchial asthma for nine years. And the effect of this therapy on preventing and treating of bronchial asthma is irrefutable. The writer did the research for describing the application method and prevention and treatment effects of point-application.Method:Patients with 6 months’ course or more were collected at the age of 18 or above, or below the age of 75, they were diagnosed definitely as bronchial asthma and belong to asthma remission phase. Totally 68 patients were differentiated with three groups. The merely application therapy group includes 28 patients,16 men and 12 women. The simultaneously taking traditional Chinese medicine group includes 10 patients,6 men and 4 women. The merely inhaling western medicine group includes 30 patients,17 men and 13 women. The merely application therapy group were treated by point-application with Chinese medicine. The simultaneously taking traditional Chinese medicine group was given oral traditional Chinese medicine in strengthening spleen and replenishing Qi or invigorating the lung and kidney. The merely inhaling western medicine group was treated with "Sha Mei Te Luo Ti Ka Song Gan Fen Xi Ru Ji". [Commercial size:60P (50ug:250ug), License number:H20090241, the manufacturer: GlaxoSmithKline].(Selecting dose guided by asthma diagnosis and treatment guideline). Course of treatment:half a year. After drug treatment observed in patients with clinical symptoms as wheezing, chest distress, cough, expectoration and attack times of asthma and common cold during half a year. Observed immune function and pulmonary function changes.Result:(1) After drug treatment, among half a year, attack times of asthma of merely application therapy group was 1.92+0.87, attack times of common cold was 5.21± 1.08; attack times of asthma of simultaneously taking traditional Chinese medicine group was 0.87±0.72, attack times of common cold was 3.06±1.92, and attack times of asthma of merely inhaling western medicine group was 3.56±0.68, attack times of common cold was 8.12±1.13.(2) After drug treatment, the immune indices including IgGã€IgAã€IgMã€CD4+〠CD4+/CD8+ of both merely application therapy group and simultaneously taking traditional Chinese medicine group had significant improvement than before, and were superior to merely inhaling western medicine group(P<0.05). While there was no significant difference between application therapy group and simultaneously taking traditional Chinese medicine group(P>0.05).Conclusion:Point-application treatment can alleviate symptoms and improve lung function of the patients. It can improve immune functions to improve life quality and decrease recurrence rate of bronchial asthma. In addition, for those patients who simultaneously take traditional Chinese medicine, there curative effect is better. |
